UroGen Pharma Ltd.
A biotechnology company focused on developing novel therapeutics for urological diseases and urinary tract tumors. The company is developing a scientifically based tumor removal formulation designed to remove tumors by non-surgical means for the treatment of non-muscle invasive bladder cancer and superficial urothelial carcinoma.
Overview
Overview | |
|---|---|
Country | United States |
State | L3 |
Employees | 204 |
Founded | 2004 |
Financials | |
|---|---|
Market Capitalization | 697.01M |
Revenue | 84.30M |
Operating Income | -69.23M |
Operating Margin | -82.12% |
Net Income | -104.32M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4615 / 5373 |
Sector : Healthcare | 793 / 1144 |
Industry : Biotechnology | 374 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2728 / 5565 |
Sector : Healthcare | 373 / 1182 |
Industry : Biotechnology | 161 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4768 / 5436 |
Sector : Healthcare | 901 / 1164 |
Industry : Biotechnology | 469 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3545 / 5330 |
Sector : Healthcare | 461 / 1174 |
Industry : Biotechnology | 138 / 667 |